Recovery After Transcervical Fibroid Ablation Versus Minimally Invasive Myomectomy for Symptomatic Uterine Fibroids:...

Area of Science:

• Gynecology
• Minimally Invasive Surgery
• Women's Health

Background:

• Symptomatic uterine fibroids affect many premenopausal women.
• Surgical options include transcervical fibroid ablation (TFA) and minimally invasive myomectomy (MIM).
• Comparative data on early recovery outcomes are crucial for treatment decisions.

Purpose of the Study:

• To compare early recovery outcomes between TFA and MIM in women with symptomatic uterine fibroids.
• To evaluate key secondary endpoints including procedure time, pain, and hospital discharge.
• To assess the short-term safety profile of both procedures.

Main Methods:

• A randomized controlled trial was conducted at Tübingen University Hospital.
• Premenopausal women (aged 18-50) with symptomatic fibroids were randomized to TFA or MIM.
• The primary endpoint was time to return to normal activities; secondary outcomes included procedure time, pain, and recovery metrics.

Main Results:

• The median time to return to normal activities was significantly shorter for TFA (5.5 days) versus MIM (13 days).
• TFA demonstrated shorter procedure times, reduced postprocedural pain, and faster discharge readiness compared to MIM.
• Nine out of ten recovery metrics favored TFA, with a comparable short-term safety profile and one serious adverse event in the MIM group.

Conclusions:

• TFA offers a faster recovery pathway for symptomatic uterine fibroids compared to MIM.
• The study supports TFA as an effective treatment option with favorable early recovery.
• Both TFA and MIM show comparable short-term safety profiles, but TFA excels in recovery speed.